Dose Proportionality of Cisatracurium
- 1 July 1997
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 37 (7) , 625-629
- https://doi.org/10.1002/j.1552-4604.1997.tb04345.x
Abstract
The dose proportionality of cisatracurium pharmacokinetics was assessed using a population approach by incorporating the collection of sparse blood samples from patients in clinical trials. Plasma concentration—time data from 131 patients with limited concentration—time data and 38 patients with full sampling were pooled and analyzed using nonlinear mixed‐effects modeling (NONMEM). Dose proportionality was assessed using dichotomous parameterization and a linear model. The population pharmacokinetic approach revealed that the pharmacokinetics of cisatracurium are independent of dose between 0.1 mg/kg and 0.4 mg/kg, as was expected based on the importance of Hofmann elimination, a chemical process dependent on pH and temperature.Keywords
This publication has 9 references indexed in Scilit:
- Prospective Use of Population Pharmacokinetics/ Pharmacodynamics in the Development of CisatracuriumPharmaceutical Research, 1997
- Importance of the Organ-Independent Elimination of CisatracuriumAnesthesia & Analgesia, 1996
- Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantationBritish Journal of Anaesthesia, 1996
- Pharmacokinetics and Pharmacodynamics of Cisatracurium in Young and Elderly Adult PatientsAnesthesiology, 1996
- Pharmacodynamics and Pharmacokinetics of Cisatracurium in Geriatric Surgical PatientsAnesthesiology, 1996
- Pharmacokinetics of Cisatracurium in Patients Receiving Nitrous Oxide/Opioid/Barbiturate AnesthesiaAnesthesiology, 1996
- The in vitro degradation of cisatracurium, the R, cis-R′-isomer of atracurium, in human and rat plasmaClinical Pharmacology & Therapeutics, 1995
- The Clinical Neuromuscular Pharmacology of 51W89 in Patients Receiving Nitrous Oxide/Opioid/Barbiturate AnesthesiaAnesthesiology, 1995
- The Cardiovascular Effects and Histamine-releasing Properties of 51W89 in Patients Receiving Nitrous Oxide/Opioid/Barbiturate AnesthesiaAnesthesiology, 1995